Icure Pharmaceutical Incorporation
Founded in 2000 and listed on KOSDAQ in 2018, Icure Pharmaceutical develops TDDS drug patches and cosmetics OEM/ODM.
As of 2026-10-10, Icure Pharmaceutical Incorporation has 181 Korean MFDS drug approvals, 2 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Products & technology
- Donepezil patchDementia treatment (improved new drug)
- Basic skincare and mask packsCosmetics OEM/ODM manufacturing
Regulatory approvals
data.go.kr181 Korean MFDS drug approvals · 2006–2025
- MFDS drugIcure Felbinac cataplasma2025-07-14Drug · OTC · Notification202501771
- MFDS drugSalimax Cool & Hot Plaster2025-04-24Drug · OTC · Notification202500978
- MFDS drugLyli-Z Enteric Coated Soft Cap2025-01-15Drug · OTC · Notification202500119
- MFDS drugbromssin tab.2024-11-26Drug · OTC · Notification202402785
- MFDS drugIcure Minoxidil Tab 5mg2024-08-19Drug · Prescription · Notification202402005
- MFDS drugMagonemaco Tab.2024-04-30Drug · OTC · Notification202401039
- MFDS drugGinkgosive Tab. 240mg(Ginkgo Leaf Dried Ext.)2024-02-07Drug · OTC · Notification202400288
- MFDS drugCuregiga Soft Cap.2023-09-05Drug · OTC · Notification202302646
- MFDS drugCurecold Plus soft cap.2023-04-12Drug · OTC · Notification202301193
- MFDS drugCureco Plus Soft Cap.2023-04-12Drug · OTC · Notification202301194
- MFDS drugCurecough Plus Soft Cap.2023-04-07Drug · OTC · Notification202301171
- MFDS drugCurecold soft cap.2023-02-23Drug · OTC · Notification202300668
Show 68 more
- MFDS drugCurecough A Soft Cap.2023-02-10Drug · OTC · Notification202300511
- MFDS drugCurecough Soft Cap.2023-01-18Drug · OTC · Notification202300295
- MFDS drugCureco Soft Cap.2022-11-14Drug · OTC · Notification202204083
- MFDS drugenertension Sol.(L-Arginine-L-Aspartate Hydrate)2022-11-04Drug · OTC · Notification202204010
- MFDS drugDonhesive Patch 175mg(Donepezil)2021-11-05Drug · Prescription · Approval202107338
- MFDS drugDonhesive Patch 87.5mg(Donepezil)2021-11-05Drug · Prescription · Approval202107339
- MFDS drugIcure Donepezil Patch50 (Donepezil)(for Export)2021-06-03Drug · Prescription · Approval202104343
- MFDS drugIcure donepezil Patch25(Donepezil)(for Export)2021-06-03Drug · Prescription · Approval202104344
- MFDS drugAitozet Tab. 10/10mg2021-02-18Drug · Prescription · Approval202101561
- MFDS drugAitozet Tab. 10/20mg2021-02-18Drug · Prescription · Approval202101562
- MFDS drugAitozet Tab. 10/40mg2021-02-18Drug · Prescription · Approval202101563
- MFDS drugS-lime Tab.(Bangpungtongsungsan Radix Dried Extract (4.6→1))Revoked2021-02-03Drug · OTC · Notification202101051
- MFDS drugToplast Menthol 5% Cataplasma (for export)2021-01-08Drug · OTC · Approval202100243
- MFDS drugToplast Lidocaine 4% Cataplasma (for export)2021-01-08Drug · OTC · Approval202100244
- MFDS drugToplast Lidocaine 4% Plus Menthol 1% Cataplasma(for export)2021-01-08Drug · OTC · Approval202100245
- MFDS drugTofacin Tab. 5mg(Tofacitinib Aspartate)Revoked2020-12-31Drug · Prescription · Approval202009444
- MFDS drugCimetop Tab.2020-09-21Drug · OTC · Notification202006476
- MFDS drugDaily Vaginal Tab.(Clotrimazole)2020-09-07Drug · OTC · Notification202006196
- MFDS drugLafutil Tab. 10mg(Lafutidine)Revoked2020-05-18Drug · Prescription · Approval202003573
- MFDS drugEripe SR Tab.(Eperisone Hydrochloride)Revoked2020-05-11Drug · Prescription · Approval202003374
- MFDS drugGripid Tab. 4mg(Glimepiride)2020-04-21Drug · Prescription · Approval202002784
- MFDS drugMytorin Tab. 10/20mgRevoked2020-04-02Drug · Prescription · Approval202002325
- MFDS drugMytorin Tab. 10/10mgRevoked2020-04-02Drug · Prescription · Approval202002326
- MFDS drugAceron Cap.(Acebrophylline)Revoked2020-03-27Drug · Prescription · Approval202002157
- MFDS drugDazole Tab.(Albendazole)2020-03-25Drug · OTC · Notification202002084
- MFDS drugPreta Tab.(Cilostazol)Revoked2020-03-21Drug · Prescription · Approval202002011
- MFDS drugAbapen Cap. 100mg(Gabapentin)Revoked2020-03-18Drug · Prescription · Approval202001878
- MFDS drugCanazole Tab. 150mg(Fluconazole)Revoked2020-03-18Drug · Prescription · Approval202001880
- MFDS drugNatopia Tab. 75mg(Naftopidil)Revoked2020-03-16Drug · Prescription · Approval202001800
- MFDS drugI-Pap Care Pop Cataplasma(Ketoprofen)2020-03-11Drug · OTC · Notification202001662
- MFDS drugEscitalo Tab. 5mg(Escitalopram Oxalate)Revoked2020-03-11Drug · Prescription · Approval202001659
- MFDS drugEscitalo Tab. 10mg(Escitalopram Oxalate)Revoked2020-03-11Drug · Prescription · Approval202001660
- MFDS drugIsole Tab. 2mg(Irsogladine Maleate)Revoked2020-03-08Drug · Prescription · Approval202001599
- MFDS drugIsole Tab. 4mg(Irsogladine Maleate)Revoked2020-03-08Drug · Prescription · Approval202001600
- MFDS drugSense-min Tab.(Diosmin)2020-03-06Drug · OTC · Notification202001565
- MFDS drugIcepirin Enteric Coated Tab.(Aspirin)Revoked2020-03-02Drug · OTC · Notification202001468
- MFDS drugSokssak Tab.Revoked2020-02-24Drug · OTC · Notification202001288
- MFDS drugFamodine Tab. 10mg(Famodine)2020-02-20Drug · OTC · Notification202001195
- MFDS drugIcure Ceftriaxone Inj. 1g(Ceftriaxone Sodium Hydrate)Revoked2020-01-23Drug · Prescription · Notification202000389
- MFDS drugLyli-Q Enteric Coated Soft Cap.Revoked2020-01-16Drug · OTC · Notification202000245
- MFDS drugIcure Cefotaxime Sodium Inj. 1gRevoked2019-12-13Drug · Prescription · Notification201908402
- MFDS drugSulfora Inj. 1g(Cefoperazone Sodium)Revoked2019-12-13Drug · Prescription · Notification201908403
- MFDS drugIperidone Tab. 3mg(Risperidone)Revoked2019-12-13Drug · Prescription · Approval201908407
- MFDS drugI-quapin Tab. 200mg(Quetiapine Fumarate)Revoked2019-12-12Drug · Prescription · Approval201908355
- MFDS drugI-quapin Tab. 300mg(Quetiapine Fumarate)Revoked2019-12-12Drug · Prescription · Approval201908356
- MFDS drugI-quapin Tab. 100mg(Quetiapine Fumarate)Revoked2019-11-12Drug · Prescription · Approval201907869
- MFDS drugI-quapin Tab. 25mg(Quetiapine Fumarate)Revoked2019-11-12Drug · Prescription · Approval201907870
- MFDS drugLotazin Plus Tab.Revoked2019-10-17Drug · Prescription · Approval201907311
- MFDS drugS-lodipine Tab. 2.5mg(S-Amlodipine Besylate Dihydrate)Revoked2019-10-16Drug · Prescription · Approval201907273
- MFDS drugS-lodipine Tab. 5mg(S-Amlodipine Besylate Dihydrate)Revoked2019-10-16Drug · Prescription · Approval201907274
- MFDS drugS-la Tab.(Bangpungtongsungsan Radix Dried Extract (4.6→1))2019-07-18Drug · OTC · Notification201904825
- MFDS drugAlbicure Tab.Revoked2019-07-12Drug · Prescription · Approval201904718
- MFDS drugHepower Solution2019-07-03Drug · OTC · Notification201904531
- MFDS drugOnefoll Tab.(Folic Acid)2019-06-26Drug · OTC · Notification201904379
- MFDS drugItocure Tab. 50mg(Itopride Hydrochloride)2019-04-24Drug · Prescription · Approval201902578
- MFDS drugZenol Powerful Plaster(Flurbiprofen)2019-01-03Drug · OTC · Notification201900024
- MFDS drugLica-L Cream(Lidocaine)2018-09-28Drug · OTC · Notification201803840
- MFDS drugBrosta Cap. 300mg(Theobromine)Revoked2018-08-21Drug · Prescription · Notification201803407
- MFDS drugMax One Plus Soft Cap.2018-07-25Drug · OTC · Notification201803085
- MFDS drugCecob Cap. 100mg(Celecoxib)2018-07-20Drug · Prescription · Approval201803009
- MFDS drugAlmas Tab.(Almagate)2018-07-11Drug · OTC · Notification201802877
- MFDS drugMontestar Tab. 10mg(Montelukast Sodium)2018-06-27Drug · Prescription · Approval201802666
- MFDS drugMonasia Tab. 1mg(Finasteride)2018-06-21Drug · Prescription · Approval201802602
- MFDS drugNoitect Tablet2018-04-13Drug · OTC · Notification201801617
- MFDS drugEllercure Tab.(Epinastine Hydrochloride)2018-03-20Drug · Prescription · Approval201801224
- MFDS drugA-ckamin Tab.(Pelargonium Sidoides 11% Ethanol Extract(1→8~10))Revoked2018-01-29Drug · Prescription · Notification201800503
- MFDS drugFerripol-M Cap.2017-11-06Drug · OTC · Notification201707836
- MFDS drugAcetine Cap.(Acetylcysteine)2017-07-10Drug · OTC · Notification201705483
Showing the 80 most recent of 181 records.
Clinical trials
data.go.kr11 MFDS clinical trial authorisations · 2012–2022 (Bioequivalence 8 · Phase 1 2 · Phase 3 1)
- Bioequivalence모사프로진정(모사프리드시트르산염수화물)2022-04-11
2 trial sites
- Bioequivalence페네도정10mg(도네페질염산염수화물)2022-04-11
2 trial sites
- Bioequivalence울파워셋정2022-04-07
2 trial sites
- Bioequivalence크레진정20밀리그램(로수바스타틴칼슘)2022-04-01
2 trial sites
- Bioequivalence클로큐어정75밀리그램(클로피도그렐황산염)2022-04-01
2 trial sites
- Bioequivalence아이큐어 펜타닐패취 25 ㎍/h2016-10-18
2 trial sites
- Phase 3도네페질패취2016-02-15
22 trial sites
- Phase 1도네페질패취2014-05-01
1 trial site
- Phase 1도네페질패취2012-07-03
1 trial site
- Bioequivalence아이큐어(주) 펜타닐패취 TTS 25㎍/h2012-02-14
2 trial sites
- Bioequivalence아이큐어(주)리바스티그민패취 10 (가칭)2012-02-03
Global clinical trials
ClinicalTrials.gov · sponsor-matchedPhase 3 · Completed · 2017-10 · NCT03197740
Phase 1 · Completed · 2014-07 · NCT02178124
Phase 1 · Completed · 2013-04 · NCT01860625
R&D and key agreements
Source: DART corporate disclosureTDDS 경피약물전달시스템 · 저분자 약물부터 단백질의약품까지 피부투과 전달 · 상업화(도네페질) · Proprietary nanocrystal, drug solubilization, skin-penetration and iontophoresis technologies
Key disclosures
KRX KIND via OpenDARTShow 8 more events
Publications
PubMed · affiliation-matched- Pharmacokinetic Evaluation by Modeling and Simulation Analysis of a Donepezil Patch Formulation in Healthy Male Volunteers.
Drug design, development and therapy · 2020-01 · Yoon SK, Bae KS, Hong DH 외 3
- Single dose pharmacokinetics of the novel transdermal donepezil patch in healthy volunteers.
Drug design, development and therapy · 2015-01 · Kim YH, Choi HY, Lim HS 외 6
Patents
KIPRIS · applicant-matchedRegistered · 2025-11 · Application 1020250164996
Published · 2025-08 · Application 1020250114122
Published · 2025-06 · Application 1020250079767
Published · 2024-11 · Application 1020240170657
Published · 2024-09 · Application 1020240120232
Published · 2024-08 · Application 1020240108402
Published · 2024-06 · Application 1020240085684
Published · 2024-05 · Application 1020240066706
- Subsidiary: (주)아이큐어비앤피REVERSE MICELLE DRUG DELIVERY SYSTEM AND ORAL PHARMACEUTICAL COMPOSITION COMPRISING SAME
PCT · Published · 2024-05 · Application PCT/KR2024/006376
Rejected · 2023-12 · Application 1020230191206
Show 92 more patents
Rejected · 2023-11 · Application 1020230168230
Registered · 2023-11 · Application 1020230154562
Registered · 2023-09 · Application 1020230127890
Registered · 2023-08 · Application 1020230101122
Registered · 2023-08 · Application 1020230101121
Registered · 2023-07 · Application 1020230089955
Registered · 2023-04 · Application 1020230055296
Published · 2023-03 · Application 1020230041558
- Subsidiary: (주)아이큐어비앤피Oral pharmaceutical composition for preventing or treating osteoporosis, containing teriparatide, and method for producing same
CN · Published · 2023-03 · Application 202380009600.1
- Subsidiary: (주)아이큐어비앤피ORAL PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF OSTEOPOROSIS CONTAINING TERIPARATIDE AND METHOD FOR PREPARATION THEREOF
US · Published · 2023-03 · Application 18268437
- Subsidiary: (주)아이큐어비앤피ORAL PHARMACEUTICAL COMPOSITION CONTAINING TERIPARATIDE FOR PREVENTION OR TREATMENT OF OSTEOPOROSIS AND PREPARATION METHOD THEREFOR
EP · Published · 2023-03 · Application 23723104.8
- Subsidiary: (주)아이큐어비앤피ORAL PHARMACEUTICAL COMPOSITION CONTAINING TERIPARATIDE FOR PREVENTION OR TREATMENT OF OSTEOPOROSIS AND PREPARATION METHOD THEREFOR
PCT · Published · 2023-03 · Application PCT/KR2023/003019
Published · 2022-11 · Application 1020220163867
Registered · 2022-11 · Application 1020220151369
Registered · 2022-11 · Application 1020220151370
- Subsidiary: (주)아이큐어비앤피COMPLEX OF LIPID NANOPARTICLES AND NOVEL CELL-PENETRATING PEPTIDES
PCT · Published · 2022-10 · Application PCT/KR2022/016753
Registered · 2022-09 · Application 1020220117745
- Subsidiary: (주)아이큐어비앤피테리파라타이드를 포함하는 골다공증 예방 또는 치료를 위한 경구용 약학적 조성물 및 이의 제조방법
Registered · 2022-07 · Application 1020220090893
- Subsidiary: (주)아이큐어비앤피COMPLEX INCLUDING CELL-PERMEABLE PEPTIDE AND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST
PCT · Published · 2022-05 · Application PCT/KR2022/006923
- Subsidiary: (주)아이큐어비앤피Cell penetrating peptide, anticancer peptide, and pharmaceutical composition for preventing or treating cancer comprising same
CN · Published · 2022-04 · Application 202280042976.8
- Subsidiary: (주)아이큐어비앤피CELL-PENETRATING PEPTIDE, ANTI-CANCER PEPTIDE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING SAME
US · Published · 2022-04 · Application 18287142
- Subsidiary: (주)아이큐어비앤피CELL-PENETRATING PEPTIDE, ANTI-CANCER PEPTIDE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING SAME
EP · Published · 2022-04 · Application 22788487.1
- Subsidiary: (주)아이큐어비앤피CELL-PENETRATING PEPTIDE, ANTI-CANCER PEPTIDE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING SAME
PCT · Published · 2022-04 · Application PCT/KR2022/005446
- Subsidiary: (주)아이큐어비앤피NOVEL PEPTIDE HAVING CELL-PENETRATING ABILITY
PCT · Published · 2021-12 · Application PCT/KR2021/018999
- Subsidiary: (주)아이큐어비앤피지질 나노입자 및 세포 투과성을 갖는 신규 펩타이드의 복합체
Withdrawn · 2021-10 · Application 1020210146624
Registered · 2021-01 · Application 1020210004615
- Subsidiary: (주)아이큐어비앤피세포막 투과성을 갖는 신규 펩타이드
Withdrawn · 2020-12 · Application 1020200175667
Registered · 2020-12 · Application 1020200169538
Registered · 2020-11 · Application 1020200156689
Registered · 2020-11 · Application 1020200145436
Registered · 2020-11 · Application 1020200145460
- Subsidiary: (주)아이큐어비앤피테리파라타이드를 포함하는 경구용 약학 조성물의 제조방법 및 이에 의해 제조된 경구용 약학 조성물
Withdrawn · 2020-10 · Application 1020200136150
- Subsidiary: (주)아이큐어비앤피비강용 약물 투여 장치
Registered · 2020-09 · Application 1020200125177
- Subsidiary: (주)아이큐어비앤피ORAL PHARMACEUTICAL COMPOSITION INCLUDING TERIPARATIDE AND METHOD FOR PREPARING SAME
US · Published · 2020-05 · Application 17640607
- Subsidiary: (주)아이큐어비앤피ORAL PHARMACEUTICAL COMPOSITION COMPRISING TERIPARATIDE AND METHOD FOR PREPARING SAME
EP · Registered · 2020-05 · Application 20861057.6
- Subsidiary: (주)아이큐어비앤피ORAL PHARMACEUTICAL COMPOSITION COMPRISING TERIPARATIDE AND METHOD FOR PREPARING SAME
PCT · Published · 2020-05 · Application PCT/KR2020/006255
- Subsidiary: (주)아이큐어비앤피리라글루타이드를 포함하는 경구용 약학 조성물의 제조방법 및 이에 의해 제조된 경구용 약학 조성물
Registered · 2020-04 · Application 1020200052304
Registered · 2020-04 · Application 1020200044510
- Subsidiary: (주)아이큐어비앤피라이신-데옥시콜산 염의 제조 방법
Abandoned · 2020-01 · Application 1020200006289
Expired · 2019-12 · Application 1020190176045
Rejected · 2019-12 · Application 1020190173764
Registered · 2019-11 · Application 1020190139485
- Subsidiary: (주)아이큐어비앤피COSMETIC COMPOSITION COMPRISING BOTULINUM-DERIVED PEPTIDE HAVING EXCELLENT CELL PENETRATING ABILITY
PCT · Published · 2019-09 · Application PCT/KR2019/011945
- Subsidiary: (주)아이큐어비앤피테리파라타이드를 포함하는 경구용 약학 조성물 및 이의 제조방법
Registered · 2019-09 · Application 1020190110078
Registered · 2019-08 · Application 1020190107497
Expired · 2019-04 · Application 1020190047765
Registered · 2019-04 · Application 1020190045569
Registered · 2019-03 · Application 1020190037204
Registered · 2018-12 · Application 1020180154535
Rejected · 2018-11 · Application 1020180137132
Rejected · 2018-11 · Application 2020180005002
- Subsidiary: (주)아이큐어비앤피Oral pharmaceutical composition containing pemetrexed and production method thereof
CN · Published · 2018-10 · Application 201880074608.5
- Subsidiary: (주)아이큐어비앤피Oral pharmaceutical composition containing pemetrexed and production method thereof
US · Registered · 2018-10 · Application 16763844
- Subsidiary: (주)아이큐어비앤피ORAL PHARMACEUTICAL COMPOSITION CONTAINING PEMETREXED AND PRODUCTION METHOD THEREOF
EP · Published · 2018-10 · Application 18888126.2
Withdrawn · 2018-09 · Application 1020180116168
Registered · 2018-09 · Application 1020180113722
Registered · 2018-02 · Application 1020180022133
Withdrawn · 2017-12 · Application 1020170173624
Registered · 2017-12 · Application 1020170172139
Rejected · 2017-12 · Application 1020170172131
- Subsidiary: (주)아이큐어비앤피페메트렉시드를 포함하는 경구용 약학 조성물 및 이의 제조방법
Expired · 2017-12 · Application 1020170171384
- Subsidiary: (주)아이큐어비앤피ORAL DRUG DELIVERY COMPOSITION CONTAINING OXALIPLATIN AND METHOD FOR PREPARING SAME
CN · Published · 2017-11 · Application 201780091976.6
- Subsidiary: (주)아이큐어비앤피Oral drug delivery composition containing oxaliplatin and method for preparing same
US · Registered · 2017-11 · Application 16621942
- Subsidiary: (주)아이큐어비앤피ORAL DRUG DELIVERY COMPOSITION CONTAINING OXALIPLATIN AND METHOD FOR PREPARING SAME
EP · Published · 2017-11 · Application 17913783.1
- Subsidiary: (주)아이큐어비앤피オキサリプラチンを含む経口用薬物送達組成物及びその製造方法
JP · Published · 2017-11 · Application 32518374
- Subsidiary: (주)아이큐어비앤피Peptide with ability to penetrate cell membrane
US · Registered · 2017-04 · Application 16092190
Registered · 2017-01 · Application 1020170007964
Withdrawn · 2016-07 · Application 1020160086814
Registered · 2016-02 · Application 1020160015829
Registered · 2015-12 · Application 1020150181809
Registered · 2014-10 · Application 1020140150278
Registered · 2013-09 · Application 1020130107556
Registered · 2013-02 · Application 1020130022199
Registered · 2012-02 · Application 1020120016100
Registered · 2011-08 · Application 1020110085296
Registered · 2011-07 · Application 1020110067738
Registered · 2011-04 · Application 1020110037946
Rejected · 2011-03 · Application 1020110022958
Registered · 2010-04 · Application 1020100038184
Registered · 2010-03 · Application 1020100021033
Rejected · 2009-09 · Application 1020090093105
Registered · 2008-03 · Application 1020080026953
Registered · 2008-03 · Application 1020080026952
Expired · 2004-01 · Application 1020040005301
Expired · 2003-11 · Application 1020030080978
Expired · 2003-11 · Application 1020030080982
Expired · 2003-10 · Application 1020030070707
Rejected · 2002-08 · Application 1020020049954
Expired · 2002-05 · Application 1020020027818
Expired · 2001-08 · Application 1020010048636
Expired · 2001-03 · Application 1020010016455
Expired · 2000-11 · Application 1020000069425
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIChatGPT-Userlive2
- OpenAIOAI-SearchBot97
- GoogleGoogleOther20
- PerplexityPerplexityBot2
- AnthropicClaudeBot2
- MicrosoftBingbot1
Measured since Aug 27, 2026 · 5 AI engines · last read Oct 9, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for Icure Pharmaceutical Incorporation and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies in the same categoryHealthcare Infrastructure
CJ CheilJedang, founded and KOSPI-listed in 2007, operates food, BIO, and logistics businesses as a CJ Group intermediate holding company.
Supplies red ginseng, probiotics, and other health functional foods to 300+ clients via OEM/ODM.
Founded in 2014 and listed on KOSDAQ in 2024, Cellromax Science is a health functional food company built on a nationwide pharmacy network.
Founded and listed on KOSDAQ in 2014, KolmarBNH develops health functional food and cosmetics materials and provides ODM/OEM manufacturing.
KOSDAQ-listed microbiome healthcare company using the PMAS gut-microbiome simulation platform and the PeachBiome028 probiotic strain.
Carelabs, founded in 2012 and KOSDAQ-listed in 2018, operates mobile healthcare and beauty care platforms.
Contract research organization providing clinical trial, post-marketing surveillance, and site management services to pharma and medtech clients.
Founded in 1998 and listed on KOSDAQ in 2021, S&D is a functional food ingredient company.
Founded in 1991 and listed on KOSDAQ in 2002, CosLeaguer Global distributes botulinum toxin and fillers and manufactures cosmetics.
Develops water-solubilized curcumin complexes for enhanced bioavailability using its WIN-T technology.
Founded and listed on KOSDAQ in 2014, GL Pharm Tech is an improved-new-drug pharmaceutical R&D company.
Founded in 1992 and listed on KOSPI in 2006, COSMAX BTI is the COSMAX Group holding company overseeing health food and cosmetics affiliates.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition